Submitted:
11 May 2024
Posted:
13 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Nuchal Translucency with and without ‘Radiant’ Applied
3. Results
3.1. Nuchal Translucency with and without ‘Radiant’ Applied
| ‘Radiant off’ vs.: | ΔNT | CI | SD | Significance |
|---|---|---|---|---|
| vs. ‘Radiant min’ | 0.19 mm | 0.17 – 0.21 | 0.010 | p < 0.001 |
| vs. ‘Radiant mid’ | 0.24 mm | 0.22 – 0.27 | 0.012 | p < 0.001 |
| vs. ‘Radiant max’ | 0.30 mm | 0.27 – 0.33 | 0.016 | p < 0.001 |
3.2. Relation of Native NT and ΔNT
3.3. In-Vitro-Examination with and without ‘Radiant’ Applied
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Conflicts of Interest
References
- Nicolaides, K.H.; Azar, G.; Byrne, D.; Mansur, C.; Marks, K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Bmj. 1992, 304, 867–9. [Google Scholar] [CrossRef]
- Russo, M.L.; Blakemore, K.J. A historical and practical review of first trimester aneuploidy screening. Semin Fetal Neonatal Med. 2014, 19, 183–7. [Google Scholar] [CrossRef] [PubMed]
- Chaoui, R.; Nicolaides, K.H. From nuchal translucency to intracranial translucency: towards the early detection of spina bifida. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2010, 35, 133–8. [Google Scholar]
- Kagan, K.O.; Wright, D.; Nicolaides, K.H. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2015, 45, 42–7. [Google Scholar]
- Moratalla, J.; Pintoffl, K.; Minekawa, R.; Lachmann, R.; Wright, D.; Nicolaides, K.H. Semi-automated system for measurement of nuchal translucency thickness. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2010, 36, 412–6. [Google Scholar]
- Karl, K.; Kagan, K.O.; Chaoui, R. Intra- and interoperator reliability of manual and semi-automated measurements of intracranial translucency. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2012, 39, 164–8. [Google Scholar]
- Wunsch, R.; Dudwiesus, H.; Reinehr, T. [Prospective comparison of different ultrasound modalities to measure thicknesses less than 1 mm]. Rofo. 2007, 179, 65–71. [Google Scholar] [CrossRef]
- Snijders, R.J.; Noble, P.; Sebire, N.; Souka, A.; Nicolaides, K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998, 352, 343–6. [Google Scholar] [CrossRef] [PubMed]
- Nicolaides, K.H. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004, 191, 45–67. [Google Scholar] [CrossRef] [PubMed]
- Kagan, K.O.; Sonek, J.; Kozlowski, P. Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet. 2022, 305, 825–35. [Google Scholar] [CrossRef]
- Mesurolle, B.; Helou, T.; El-Khoury, M.; Edwardes, M.; Sutton, E.J.; Kao, E. Tissue harmonic imaging, frequency compound imaging, and conventional imaging: use and benefit in breast sonography. J Ultrasound Med. 2007, 26, 1041–51. [Google Scholar] [CrossRef]







| Normal | Trisomy 21 | Trisomy 18 | Monosomy X | |
|---|---|---|---|---|
| n | 259 (98.48 %) | 1 (0.38 %) | 2 (0.78 %) | 1 (0,38 %) |
| Mean GA | 12w 4d | 11w 6d | 11w 6d | 11w 2d |
| Mean CRL | 64 mm | 52 mm | 51 mm | 52 mm |
| Mean NT | 1.98 | 6.97 | 6.36 | 7.10 |
| Mean age | 34 | 42 | 33 | 31 |
| Mean BMI | 25,7 | 24,9 | 20,4 | 26,0 |
| NIPT rate | 61 (23.6 %) | 0 | 0 | 0 |
| AC rate | 0 | 0 | 0 | 0 |
| CVS rate | 4 (1.5 %) | 1 (100 %) | 2 (100 %) | 1 (100 %) |
| ICSI / IVF | 17 (6,6 %) | 1 (100 %) | 0 | 0 |
| 1.0 mm | Fundamental | HI High | Ultra HD |
|---|---|---|---|
| Radiant off | 0.70 | 0.70 | 0.80 |
| Radiant min. | 0.90 | 0.70 | 0.90 |
| Radiant mid. | 0.90 | 0.70 | 1.00 |
| Radiant max. | 0.80 | 0.70 | 0.90 |
| 2.5 mm | Fundamental | HI High | Ultra HD |
|---|---|---|---|
| Radiant off | 2.20 | 1.60 | 2.30 |
| Radiant min. | 2.20 | 1.70 | 2.60 |
| Radiant mid. | 2.30 | 2.10 | 2.60 |
| Radiant max. | 2.40 | 2.10 | 2.60 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).